Chris Centeno

Regenexx Corporate Program

Regenexx was the first to use stem cells to treat orthopedic injuries, and we've published roughly half of all worldwide research in their application. With more than 6 million covered lives across the country, Regenexx uses our advanced regenerative technologies to help self-funded employers save up to 80% of their orthopedic healthcare costs by providing an effective, low-cost alternative to roughly 70% of orthopedic surgeries. If given the choice between an orthopedic surgery, or a non-invasive treatment to eliminate pain and improve function and mobility, employees choose the latter 99% of the time. The Regenexx process of treating musculoskeletal conditions involves a high level of physician skill and our patented, research-based protocols that allow us to realize outcomes that can only be achieved through our high standards of practice. We license our patented Interventional Orthopedics procedures to physicians across the country who are part of the Regenexx network. These expert physicians receive intensive initial and ongoing training and support. Learn more about Regenexx and how we help employers take control of their health care spend. Visit www.Regenexxcorporate.com for more information.